Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284010 · ClinicalTrials.gov registry record
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 200
- Enrollment target
NCT01284010: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT01284010 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01284010 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood and bone marrow samples from patients with acute lymphoblastic leukemia.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC mutation analysis
- GENETIC DNA analysis
- GENETIC fluorescence in situ hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-09 |
What the finished NCT01284010 record still lists
NCT01284010 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01284010 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01284010 about?
NCT01284010 is a clinical study titled "Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia". RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood and bone marrow samples from patients ...
What is the current status of trial NCT01284010?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2011-02. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01284010?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), mutation analysis (GENETIC), DNA analysis (GENETIC), fluorescence in situ hybridization (GENETIC).
Who is sponsoring clinical trial NCT01284010?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia